Tandem Diabetes Care CEO John Sheridan's 2019 pay jumps 445% to $11M
Tandem Diabetes Care reports 2019 executive compensation
By ExecPay News
Published: April 14, 2020
Tandem Diabetes Care reported fiscal year 2019 executive compensation information on April 14, 2020.
In 2019, six executives at Tandem Diabetes Care received on average a compensation package of $7.1M, a 233% increase compared to previous year.
Average pay of disclosed executives at Tandem Diabetes Care
John F. Sheridan, Chief Executive Officer, received $11M in total, which increased by 445% compared to 2018. 88% of Sheridan's compensation, or $9.3M, was in option awards. Sheridan also received $738K in non-equity incentive plan, $500K in salary, as well as $3.6K in other compensation.
For fiscal year 2019, the median employee pay was $105,295 at Tandem Diabetes Care. Therefore, the ratio of John F. Sheridan's pay to the median employee pay was 100 to one.
Kim D. Blickenstaff, Chief Executive Officer, received a compensation package of $11M, which increased by 253% compared to previous year. 88% of the compensation package, or $9.2M, was in option awards.
Brian B. Hansen, Executive Vice President, Chief Commercial Officer, earned $5.4M in 2019, a 179% increase compared to previous year.
Leigh A. Vosseller, Chief Financial Officer, received $5.4M in 2019, which increases by 185% compared to 2018.
David B. Berger, Secretary, earned $5.4M in 2019, a 179% increase compared to previous year.
Susan Morrison, Chief Administrative Officer, received $5.4M in 2019.
Related executives
Kim Blickenstaff
Tandem Diabetes Care
Chief Executive Officer
John Sheridan
Tandem Diabetes Care
Chief Executive Officer
Leigh Vosseller
Tandem Diabetes Care
Chief Financial Officer
David Berger
Tandem Diabetes Care
Chief Operating Officer
Brian Hansen
Tandem Diabetes Care
Executive Vice President, Chief Commercial Officer
Susan Morrison
Tandem Diabetes Care
Chief Administrative Officer
You may also like
Source: SEC filing on April 14, 2020.